Trade Taisei Corporation - 1801 CFD

Trading Conditions

• Type: CFD
• Spread: 45.8
• Long position overnight funding adjustment: -0.01305%
• Short position overnight funding adjustment: -0.00917%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: JPY
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: Japan
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 16674.2
• Open: 15623.8
• 1-Year Change: 271.39%
• Day's Range: 15470.9 - 16374.6

What is Taisei Corporation (1801)?

Taisei Corporation is a major Japanese construction company engaged in civil engineering, building construction, and real estate development. It undertakes a wide range of projects including infrastructure development such as roads, bridges, tunnels, and airports, as well as commercial and residential buildings. The company provides comprehensive construction services from design and planning to project management and execution. Taisei Corporation is involved in both domestic and international markets, contributing to urban development and infrastructure modernization. It emphasizes safety, quality, and environmental sustainability in its construction practices.

Taisei Corporation Stock Price Today: Live Overview

The price today is shaped by current session fluctuations with Taisei Corporation at ¥16374.4. It has traded between ¥15389 and ¥16527.9 during the day, showing a daily price change of -2.3533%.

FAQ: Taisei Corporation (1801)

What is the current price of 1801 stock?

Taisei Corporation's current stock price is ¥16374.4.

Does 1801 pay dividends?

Taisei Corporation pays dividends to its shareholders.

Does 1801 have a formal corporate presence or regional headquarters in the UAE?

Taisei Corporation operates via partners and distributors in the UAE without an official regional office.

What is 1801 best known for?

Taisei Corporation is most famous for its construction and civil engineering projects.

What assets are typically shown together with 1801?

Commonly shown alongside 1801: CoreCivic, Inc., Dyne Therapeutics, Inc., CNO Financial Group Inc